{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:56:40Z","timestamp":1788793000254,"version":"build-2803163510"},"reference-count":54,"publisher":"European Respiratory Society (ERS)","issue":"158","license":[{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2020,6,29]]},"published-print":{"date-parts":[[2020,12,31]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Atrial septal defect (ASD) is a common form of congenital heart disease. Significant shunts may increase the risk of developing pulmonary hypertension (PH). We aimed to describe current PH definitions, evaluate PH prevalence and the effect of PH on outcomes in patients undergoing percutaneous ASD closure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>EMBASE, MEDLINE and Cochrane databases were systematically searched. Studies reporting PH prevalence or mean systolic pulmonary arterial pressure (sPAP) before and after percutaneous ASD closure in adults were included. We conducted meta-analyses to obtain summary estimates for PH prevalence and mean sPAP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>15 articles with a total of 1073 patients met the eligibility criteria. Studies applied variable PH definitions. PH prevalence and mean sPAP levels decreased in all studies after closure. The pooled PH prevalence decreased from 44% (95% CI 29\u201360%) to 18% (95% CI 8\u201327%). The overall standardised mean difference in sPAP was 1.12 (95% CI 0.81\u20131.44) and 1.62 (95% CI 1.00\u20132.23) in cohort and case-series studies respectively indicating a large decrease. The pooled standard mean difference among the younger and older patients were different, 1.25 (95% CI 0.78\u20131.71) and 0.91 (95% CI 0.56\u20131.27), respectively. A high degree of between-study heterogeneity was noted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Both PH prevalence and mean sPAP decrease after ASD closure. Larger, prospective studies with consistent PH definitions using the recommended measurement modality are warranted.<\/jats:p><\/jats:sec>","DOI":"10.1183\/16000617.0099-2020","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T22:14:47Z","timestamp":1608156887000},"page":"200099","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Prevalence and outcomes of pulmonary hypertension after percutaneous closure of atrial septal defect: a systematic review and meta-analysis"],"prefix":"10.1183","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5851-0909","authenticated-orcid":false,"given":"Selai","family":"Akseer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Horlick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varnita","family":"Vishwanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hobbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Huszti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lusine","family":"Abrahamyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2020,12,15]]},"reference":[{"key":"2024102403501673000_29.158.200099.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.08.025"},{"key":"2024102403501673000_29.158.200099.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.008396"},{"key":"2024102403501673000_29.158.200099.3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.107.3.e32"},{"issue":"Suppl. 24","key":"2024102403501673000_29.158.200099.4","doi-asserted-by":"crossref","first-page":"S2882","DOI":"10.21037\/jtd.2018.02.17","article-title":"Hemodynamic assessment of atrial septal defects","volume":"10:","author":"Torres","year":"2018","journal-title":"J Thorac Dis"},{"key":"2024102403501673000_29.158.200099.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)02134-8"},{"key":"2024102403501673000_29.158.200099.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2013.08.009"},{"key":"2024102403501673000_29.158.200099.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2005.07.053"},{"key":"2024102403501673000_29.158.200099.8","first-page":"e698","article-title":"2018 AHA\/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Stout","year":"2019","journal-title":"Circulation"},{"key":"2024102403501673000_29.158.200099.9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1253\/circj.CJ-15-0599","article-title":"Treat and repair strategy in patients with atrial septal defect and significant pulmonary arterial hypertension","volume":"80","author":"Akagi","year":"2016","journal-title":"Circ J"},{"key":"2024102403501673000_29.158.200099.10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv317"},{"key":"2024102403501673000_29.158.200099.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2007.04.044"},{"key":"2024102403501673000_29.158.200099.12","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.1_suppl.78S"},{"key":"2024102403501673000_29.158.200099.13","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01913-2018"},{"key":"2024102403501673000_29.158.200099.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.08.1032"},{"key":"2024102403501673000_29.158.200099.15","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.71.3.224"},{"key":"2024102403501673000_29.158.200099.16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1586\/14779072.2015.1047763","article-title":"Approaching atrial septal defects in pulmonary hypertension","volume":"13","author":"Schwerzmann","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2024102403501673000_29.158.200099.17","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.10700"},{"key":"2024102403501673000_29.158.200099.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.08.009"},{"key":"2024102403501673000_29.158.200099.19","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00004712"},{"key":"2024102403501673000_29.158.200099.20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1976.03260490024013"},{"key":"2024102403501673000_29.158.200099.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01862-4"},{"key":"2024102403501673000_29.158.200099.22","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV7I3A63"},{"key":"2024102403501673000_29.158.200099.23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.5.521"},{"key":"2024102403501673000_29.158.200099.24","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1"},{"key":"2024102403501673000_29.158.200099.25","unstructured":"Covidence systematic review software . Veritas Health Innovation, Melbourne, Australia. www.covidence.org"},{"key":"2024102403501673000_29.158.200099.26","unstructured":"Moola S , Munn Z , Tufanaru C , et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E , Munn Z , eds. Joanna Briggs Institute Reviewer's Manual, Adelaide, The Joanna Briggs Institute, 2017."},{"key":"2024102403501673000_29.158.200099.27","unstructured":"R Core Team . R: A language and environment for statistical computing. Vienna, R Foundation for Statistical Computing, 2019."},{"key":"2024102403501673000_29.158.200099.28","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"2024102403501673000_29.158.200099.29","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v036.i11"},{"key":"2024102403501673000_29.158.200099.30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2024102403501673000_29.158.200099.31","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01305-5"},{"key":"2024102403501673000_29.158.200099.32","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2002.126121"},{"key":"2024102403501673000_29.158.200099.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.2007.00324.x"},{"key":"2024102403501673000_29.158.200099.34","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.114660"},{"key":"2024102403501673000_29.158.200099.35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.108.826560"},{"key":"2024102403501673000_29.158.200099.36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0803.2008.00245.x"},{"key":"2024102403501673000_29.158.200099.37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s12471-010-0830-1","article-title":"Transcatheter device closure of atrial septal defects in patients aged 40 years and older","volume":"18","author":"Altindag","year":"2010","journal-title":"Neth Heart J"},{"key":"2024102403501673000_29.158.200099.38","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq352"},{"key":"2024102403501673000_29.158.200099.39","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-011-0187-4"},{"key":"2024102403501673000_29.158.200099.40","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.23119"},{"key":"2024102403501673000_29.158.200099.41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ccd.23457","article-title":"Transcatheter closure of atrial septal defect in a geriatric population","volume":"80","author":"Nakagawa","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"2024102403501673000_29.158.200099.42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/2211-4122.123028","article-title":"Long-term results after percutaneous closure of atrial septal defect: cardiac remodeling and quality of life","volume":"23","author":"Mangiafico","year":"2013","journal-title":"J Cardiovasc Echogr"},{"key":"2024102403501673000_29.158.200099.43","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00380-016-0886-y","article-title":"Mid-to-long-term follow-up results of transcatheter closure of atrial septal defect in patients older than 40\u2005years","volume":"32","author":"Wang","year":"2017","journal-title":"Heart Vessels"},{"key":"2024102403501673000_29.158.200099.44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ccd.27853","article-title":"Device closure of atrial septal defect with severe pulmonary hypertension in adults: patient selection with early and intermediate term results","volume":"93","author":"Dalvi","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"2024102403501673000_29.158.200099.45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ahj.2018.03.020","article-title":"The prevalence of pulmonary arterial hypertension before and after atrial septal defect closure at adult age: a systematic review","volume":"201","author":"Zwijnenburg","year":"2018","journal-title":"Am Heart J"},{"key":"2024102403501673000_29.158.200099.46","doi-asserted-by":"crossref","first-page":"17B","DOI":"10.1016\/S0828-282X(10)71069-2","article-title":"Imaging in pulmonary hypertension: echocardiography, computed tomography and cardiac magnetic resonance imaging","volume":"26","author":"Beauchesne","year":"2010","journal-title":"Can J Cardiol"},{"key":"2024102403501673000_29.158.200099.47","first-page":"923","article-title":"Accuracy of Doppler echocardiography in the assessment of pulmonary arterial hypertension in patients with congenital heart disease","volume":"17","author":"Wang","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2024102403501673000_29.158.200099.48","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.4.1313"},{"key":"2024102403501673000_29.158.200099.49","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001103"},{"key":"2024102403501673000_29.158.200099.50","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00038-2019"},{"key":"2024102403501673000_29.158.200099.51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0803.2007.00104.x"},{"key":"2024102403501673000_29.158.200099.52","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-009-0105-2"},{"key":"2024102403501673000_29.158.200099.53","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2013.43.2.110"},{"key":"2024102403501673000_29.158.200099.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2005.03.027"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0099-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:02:28Z","timestamp":1740373348000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0099-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,15]]},"references-count":54,"journal-issue":{"issue":"158","published-online":{"date-parts":[[2020,12,15]]},"published-print":{"date-parts":[[2020,12,31]]}},"alternative-id":["10.1183\/16000617.0099-2020"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0099-2020","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,15]]}}}